MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 160 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2014. The put-call ratio across all filers is 40.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,185,000 | -8.6% | 66,933 | -0.4% | 0.04% | -8.5% |
Q3 2016 | $1,297,000 | -18.0% | 67,223 | -17.2% | 0.05% | -25.4% |
Q2 2016 | $1,582,000 | +2.9% | 81,140 | +8.7% | 0.06% | -3.1% |
Q1 2016 | $1,538,000 | -12.6% | 74,640 | -13.0% | 0.06% | -16.7% |
Q4 2015 | $1,760,000 | +7.8% | 85,780 | -10.1% | 0.08% | +9.9% |
Q3 2015 | $1,632,000 | -46.7% | 95,450 | -41.9% | 0.07% | -38.8% |
Q2 2015 | $3,062,000 | -37.9% | 164,250 | -36.4% | 0.12% | -34.8% |
Q1 2015 | $4,927,000 | -44.7% | 258,220 | -52.3% | 0.18% | -43.3% |
Q4 2014 | $8,906,000 | -9.5% | 541,050 | -2.8% | 0.31% | -11.5% |
Q3 2014 | $9,846,000 | +10.3% | 556,591 | +28.6% | 0.36% | +12.3% |
Q2 2014 | $8,930,000 | +10.7% | 432,640 | +16.9% | 0.32% | +7.8% |
Q1 2014 | $8,065,000 | +407.2% | 370,110 | +517.6% | 0.29% | +405.2% |
Q4 2013 | $1,590,000 | +71.0% | 59,930 | +52.3% | 0.06% | +56.8% |
Q3 2013 | $930,000 | +65.8% | 39,350 | +50.7% | 0.04% | +60.9% |
Q2 2013 | $561,000 | – | 26,110 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |